APhA Pharmacy Law Matters: A Year in Review Affecting Pharmacy in 2020

Activity Preview

In 2020, the federal government took action through enforcement discretion and flexibility of certain statutory requirements to expand new scope-of-practice authorities to make it easier for pharmacists and other health professionals to provide care to patients in response to the COVID-19 public health emergency. Recognizing pharmacists’ accessibility in communities across the country, the federal government has turned to pharmacists as critical access points for COVID-19 testing and immunization. This article, which is current as of December 2020, describes 2020 federal legislative and regulatory activities affecting pharmacy practice, including new and proposed policy changes.  

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Describe the government action (legislative and regulatory) to address COVID-19 and the impact on pharmacists' practices.
  • List examples of recent federal legislative activity that impact the practice of pharmacy.
  • Describe the latest federal regulations related to the practice of pharmacy.

Activity Type: Knowledge-based
Target Audience: Pharmacists and Pharmacy Technicians
Learning Level: 1

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours of CPE credit (0.10 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-118-H03-P/T.  

To obtain credit for APhA Pharmacy Law Matters: A Year in Review: Legal and Regulatory Developments Affecting Pharmacy in 2020, complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: January 1, 2021
Expiration date: January 1, 2024 - No credit can be earned after this date

Development

APhA Pharmacy Law Matters: A Year in Review: Legal and Regulatory Developments Affecting Pharmacy in 2020, is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association

Advisory Board

Michael A. Mone, BSPharm, JD Vice President, Associate General Counsel for Regulatory Affairs Cardinal Health
Ilisa BG Bernstein, PharmD, JD Senior Vice President, Pharmacy Practice & Government Affairs, APhA
Alicia Kerry Mica, Senior Lobbyist, APhA
Michael Baxter, Senior Director, Regulatory Policy, APhA
Karin Bolte, JD, Director, Health Policy, APhA

Disclosures

APhA’s Government Affairs and editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-118-H03-P 0.1 CEUs January 01, 2021 - January 01, 2024
ACPE# 0202-0000-21-118-H03-T 0.1 CEUs January 01, 2021 - January 01, 2024